OBI Pharma, Inc   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Taipei Taiwan (2002)

Organization Overview

First Clinical Trial
2011
NCT01516307
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

OBI Pharma, Inc